Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Idaho by County

Breast (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

Line by Line Interpretation of the Report



Gooding County7

Cassia County7

Madison County7

Valley County7

Idaho County7

Payette County7

Bonner County7

Gem County7

Nez Perce County7

Jefferson County7

Bonneville County7

Fremont County7

Blaine County7

Kootenai County7

Bingham County7

Boundary County7

Washington County7

Owyhee County7

Ada County7

Canyon County7

Minidoka County7

Latah County7

Jerome County7

Twin Falls County7

Bannock County7

Elmore County7

Adams County7 Bear Lake County7 Benewah County7 Boise County7 Butte County7 Camas County7 Caribou County7 Clark County7 Clearwater County7 Custer County7 Franklin County7 Lemhi County7 Lewis County7 Lincoln County7 Oneida County7 Power County7 Shoshone County7 Teton County7

Created by on 07/14/2024 7:42 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Adams, Bear Lake, Benewah, Boise, Butte, Camas, Caribou, Clark, Clearwater, Custer, Franklin, Lemhi, Lewis, Lincoln, Oneida, Power, Shoshone, Teton

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.